Skip to main content
. 2014 Dec 15;7(12):5826–5831.

Table 4.

The clinical data of vaginal intraepithelial neoplasia (VAIN) patients

CIN III CSCC II a2 CSCC I a2# CSCC II a1 CSCC II a1 CSCC I b1
Operation time Aug. 2009 Jan. 2009 Jan. 2009 Feb. 2009 Mar. 2010 May. 2010
Preoperative high-risk HPV 374.96 807.36 1084.62 380.25 1430.04 951.07
VAIN diagnosis time VAIN II in Mar. 2012 VAIN I in Nov. 2010 VAIN III in Oct. 2011 VAIN III recurrence in Jun. 2012 VAIN III in Jun. 2011 VAIN III in Feb. 2011 VAIN III in Apr. 2013
High-risk HPV value in VAIN 0.87 1530.83 1520.92 1154.61 during 2nd surgery 53.46 5.38 947.24
Continuous infection time by high-risk HPV - 5 months 42 months 18 months -## 35 months
Therapies Laser therapy Interferon therapy Resection by 2 surgeries Resection by surgery Resection by surgery Resection by surgery
Patient outcomes after follow-up TCT (-) HPV 0.26 HPV 0.33 and TCT (-) in Apr. 2011; Died of intestinal obstruction in Jun. 2012 TCT (-) HPV 5.33 TCT (-) HPV 1.35 TCT (-) HPV 0.51 TCT (-) HPV 54.3

Note: CIN, cervical intraepithelial neoplasia; CSCC, cervical squamous cell carcinoma.

#

this patient had sustained infection by high-risk HPV before and after surgery. In month 22 after the surgery, 2 × 2.5 erosion surface was found on the left side of vaginal cuff. TCT result indicated squamous cell carcinoma and colposcopy confirmed VAIN III. After surgical resection, TCT result was negative, but the patient still had infection by high-risk HPV. Seven months later, VAIN III was diagnosed again before surgical treatment was carried out.

##

This patient had a semi-quantitative HPV-DNA value of 0.25 and negative TCT result 3 months after the surgery. Eleven months after the surgery, high-risk HPV-DNA was 5.38, TCT result was HSIL, and VAIN III was diagnosed by colposcopy. Time of sustained infection by high-risk HPV was unclear.